Study reveals the adverse effects of prenatal exposure to ethylene oxide on fetal development

FHS
June 27, 2024
5:59 pm

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation, provides new evidence on the adverse effects of prenatal exposure to ethylene oxide (EO) on foetal development.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

In an analysis of the phase III CEPHEUS trial presented at the American Society of Hematology annual meeting, adding daratumumab (Darzalex) to bortezomib (Velcade), lenalidomide

December 24, 2024

New study reveals higher mortality risk in COVID-19 patients with newly-diagnosed atrial fibrillation

The incidence and prognosis of newly diagnosed AF in patients hospitalized due to SARS-CoV-2.

January 12, 2024

Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis

Certain clinical characteristics were negatively associated with achieving a response to biologic therapies in patients with psoriasis, a meta-analysis showed. Using data from 31 observational

June 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.